Chris Jacobs’ purchase of IVERIC Bio ( $ISEE ) on July 18th.
7. Chris Jacobs’ purchase of IVERIC Bio ( $ISEE ) on July 18th. Since then, the stock has risen over 92% as the biopharmaceutical company has announced positive data from their clinical trial and received a favorable designation from the FDA.
Since then, the stock has risen over 92% as the biopharmaceutical company has announced positive data from their clinical trial and received a favorable designation from the FDA.